Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve the standalone and consolidated financial results for the quarter ended June 30, 2025
Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2025
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Titan Biotech Limited on 6ix
Story so far
- Board Meeting Intimation for Consideration & Approval Of The Audited (Standalone & Consolidated) Financial Results For The Quarter And Financial Year Ended March 31, 2025 And Consideration Of Recommendation Of Final Dividend, If Any For The Financial
- Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Financial Results For Quarter Ending On 31St December, 2024
Earlier from Titan Biotech
- Titan Biotech Limited Press Release Jul 25 2025
- Announcement On Legal Notice Invoking Arbitration In A Disputed Matter
- Titan Biotech Limited Press Release Jul 24 2025
- Announcement Regarding Receipt Of Legal Notice Invoking Arbitration In A Disputed Matter.
- Titan Biotech Limited Press Release Jun 21 2025
Later from Titan Biotech
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Titan Biotech Limited Press Release Aug 07 2025
- Unaudited Financial Results For Quarter Ended June 2025
- Board Meeting Outcome for Outcome Of Board Meeting Held On August 13, 2025
- Announcement under Regulation 30 (LODR)-Change in Directorate
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech